Drugs / Lu AA34893
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00766870 | Sep 2008 → Jan 2009 | major depressive disorder | H. Lundbeck A/S | Terminated | No outcome recorded |
| Phase 2 | NCT00622245 | Jan 2008 → Jan 2009 | bipolar depression | H. Lundbeck A/S | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AA34893 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00622245 ↗ |
| Route | Oral | “per oral doses, divided in twice daily administrations as capsules, during 12 weeks, followed by a one-week tapering period” NCT00622245 ↗ |